Genmab A/S
Antibodies binding AXL
Last updated:
Abstract:
The present disclosure relates to anti-AXL antibodies, immunoconjugates, compositions and method of treatment of cancer with such anti-AXL antibodies, immunoconjugates, or compositions.
Status:
Grant
Type:
Utility
Filling date:
10 Jul 2015
Issue date:
24 Dec 2019